TY - JOUR
T1 - Synthesis of a 1α-C-methyl analogue of 25-hydroxyvitamin D3
T2 - interaction with a mutant vitamin D receptor Arg274Leu
AU - Honzawa, Shinobu
AU - Takahashi, Naoyuki
AU - Yamashita, Atsushi
AU - Sugiura, Takayuki
AU - Kurihara, Masaaki
AU - Arai, Midori A.
AU - Kato, Shigeaki
AU - Kittaka, Atsushi
N1 - Funding Information:
We are grateful to Ms. Junko Shimode and Ms. Akiko Tonoki (Teikyo University) for the spectroscopic measurements. This work has been supported in part by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (#17790095 to S.H.), and by Grant-in-Aid from Japan Society for the Promotion of Science (#17590012 to A.K.). A.K. gratefully acknowledges Uehara Memorial Foundation.
PY - 2009/8/22
Y1 - 2009/8/22
N2 - Vitamin D3 analogues have been developed for a mutant vitamin D receptor (VDR), Arg274Leu. The mutant VDR has a mutation at Arg274, which forms an important hydrogen bond with 1α-OH of 1α,25-dihydroxyvitamin D3 to anchor the ligand tightly in the VDR ligand binding pocket. Stereoselective synthesis of the A-ring part of the novel vitamin D analogue, 2α-(3-hydroxypropyl)-1α-methyl-25-hydroxyvitamin D3 (4), from d-galactose was accomplished with the key steps of the introduction of the methyl and allyl groups to the chiral building blocks. The new analogue 4 is ca. 7.3-fold more active than the natural hormone 1α,25-dihydroxyvitamin D3 (1).
AB - Vitamin D3 analogues have been developed for a mutant vitamin D receptor (VDR), Arg274Leu. The mutant VDR has a mutation at Arg274, which forms an important hydrogen bond with 1α-OH of 1α,25-dihydroxyvitamin D3 to anchor the ligand tightly in the VDR ligand binding pocket. Stereoselective synthesis of the A-ring part of the novel vitamin D analogue, 2α-(3-hydroxypropyl)-1α-methyl-25-hydroxyvitamin D3 (4), from d-galactose was accomplished with the key steps of the introduction of the methyl and allyl groups to the chiral building blocks. The new analogue 4 is ca. 7.3-fold more active than the natural hormone 1α,25-dihydroxyvitamin D3 (1).
KW - Mutant vitamin D receptor
KW - Structure-function relationships
KW - Vitamin D analogue
KW - Vitamin D receptor
UR - http://www.scopus.com/inward/record.url?scp=67650561456&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67650561456&partnerID=8YFLogxK
U2 - 10.1016/j.tet.2009.06.029
DO - 10.1016/j.tet.2009.06.029
M3 - Article
AN - SCOPUS:67650561456
SN - 0040-4020
VL - 65
SP - 7135
EP - 7145
JO - Tetrahedron
JF - Tetrahedron
IS - 34
ER -